论文部分内容阅读
人类肿瘤特异性免疫治疗的重要物质基础是肿瘤抗原的存在,90年代以来,随着 T 细胞识别机制的阐明,重组 DNA 技术的发展及癌基因研究的深入,在肿瘤抗原的性质、表位结构以及利用肿瘤抗原对肿瘤进行治疗等方面,
The important material basis of human tumor-specific immunotherapy is the presence of tumor antigens. Since the 1990s, with the elucidation of T cell recognition mechanisms, the development of recombinant DNA technology and the in-depth study of oncogenes, the nature of tumor antigens, and the structure of epitopes As well as using tumor antigens to treat tumors, etc.